Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study - Hamid, Omid; Hassel, Jessica C.; Shoushtari, Alexander N.; Meier, Friedegund; Bauer, Todd M.; Salama, April K. S.; Kirkwood, John M.; Ascierto, Paolo A.; Lorigan, Paul C.; Mauch, Cornelia; Orloff, Marlana; Evans, Thomas R. Jeffry; et al. (Journal for ImmunoTherapy of Cancer, 2023)
Accepted 12 May 2023